Literature DB >> 25301204

Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice.

Valérie Conway1, Annie Larouche2, Wael Alata3, Milène Vandal4, Frédéric Calon4, Mélanie Plourde5.   

Abstract

Evidences suggest that omega-3 fatty acid (n-3 PUFA) metabolism is imbalanced in apolipoprotein E epsilon 4 isoform carriers (APOE4). This study aimed to investigate APOE genotype-dependant modulation of FA profiles, protein and enzyme important to fatty acid (FA) metabolism in the adipose tissue, the liver and the plasma using human APOE-targeted replacement mouse-model (N=37). FA transport (FATP) and binding (FABP) protein levels in tissues and concentrations of liver carnitine palmitoyltransferase 1 (CPT1) were performed. N-3 PUFA concentration was >45% lower in the adipose tissue and liver of APOE4 mice compared to APOE3 mice. In APOE4 mice, there were higher levels of FATP and FABP in the liver and higher FATP in the adipose tissue compared to APOE2 mice. There was a trend towards higher CPT1 concentrations in APOE4 mice compared to APOE3 mice. Therefore, since APOE-isoform differences were not always in line with the unbalanced n-3 PUFA profiles in organs, other proteins may be involved in maintaining n-3 PUFA homeostasis in mice with different APOE-isoforms.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APOE4 carriers.; Cellular FA uptake and degradation; Transport and binding proteins; n-3 PUFA metabolism

Mesh:

Substances:

Year:  2014        PMID: 25301204     DOI: 10.1016/j.plefa.2014.09.007

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  7 in total

1.  A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE ε4 Carriers.

Authors:  G M Fote; N R Geller; A M Reyes-Ortiz; L M Thompson; J S Steffan; J D Grill
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

2.  Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.

Authors:  Natalie Tomaszewski; Xulei He; Victoria Solomon; Mitchell Lee; Wendy J Mack; Joseph F Quinn; Meredith N Braskie; Hussein N Yassine
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?

Authors:  Raphaël Chouinard-Watkins; Mélanie Plourde
Journal:  Nutrients       Date:  2014-10-20       Impact factor: 5.717

4.  The effect of dietary fish oil on weight gain and insulin sensitivity is dependent on APOE genotype in humanized targeted replacement mice.

Authors:  Kenna E Slim; David Vauzour; Noemi Tejera; Peter J Voshol; Aedin Cassidy; Anne Marie Minihane
Journal:  FASEB J       Date:  2016-11-28       Impact factor: 5.191

Review 5.  APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.

Authors:  Hussein N Yassine; Caleb E Finch
Journal:  Front Aging Neurosci       Date:  2020-06-10       Impact factor: 5.750

6.  LPC-DHA/EPA-Enriched Diets Increase Brain DHA and Modulate Behavior in Mice That Express Human APOE4.

Authors:  Sarah B Scheinman; Dhavamani Sugasini; Monay Zayed; Poorna C R Yalagala; Felecia M Marottoli; Papasani V Subbaiah; Leon M Tai
Journal:  Front Neurosci       Date:  2021-07-01       Impact factor: 4.677

7.  Postprandial enrichment of triacylglycerol-rich lipoproteins with omega-3 fatty acids: lack of an interaction with apolipoprotein E genotype?

Authors:  Valérie Conway; Marie-Julie Allard; Anne-Marie Minihane; Kim G Jackson; Julie A Lovegrove; Mélanie Plourde
Journal:  Lipids Health Dis       Date:  2014-09-16       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.